Yuvraj S. Chowdhury1,
Cristina A Mitre2,
Vittorio E. Rotella3,
Karan Garg4,
David K Lee5,
Pooja Belligund5,
Lu Chen2,
Paul Madaj1,
Haytham A Aboushi6,
Mohammad R. Al-Ajam5,
Samy I. McFarlane6,
1Division of Cardiovascular Disease and Department of Internal Medicine, State University of New York: Downstate Medical Center, Brooklyn, New York, United States-11203
2Division of Cardiovascular Disease, VA NY Harbor Healthcare System, Brooklyn Campus, New York -11209
3Division of Vascular Surgery, VA NY Harbor Healthcare System, Brooklyn Campus, New York- 11209
4Division of Vascular Surgery, VA NY Harbor Healthcare System, Manhattan VA Medical Center, New York- 10010
5Division of Pulmonology and Critical Care, VA NY Harbor Healthcare System, Brooklyn Campus, New York- 11209
6Department of Internal Medicine, State University of New York: Downstate Medical Center, Brooklyn, New York, United States-11203
American Journal of Medical Case Reports.
2020,
Vol. 8 No. 12, 486-490
DOI: 10.12691/ajmcr-8-12-15
Copyright © 2020 Science and Education PublishingCite this paper: Yuvraj S. Chowdhury, Cristina A Mitre, Vittorio E. Rotella, Karan Garg, David K Lee, Pooja Belligund, Lu Chen, Paul Madaj, Haytham A Aboushi, Mohammad R. Al-Ajam, Samy I. McFarlane. Extensive Peripheral Arterial Thrombosis in a Patient with SARS-CoV-2 Infection.
American Journal of Medical Case Reports. 2020; 8(12):486-490. doi: 10.12691/ajmcr-8-12-15.
Correspondence to: Samy I. McFarlane, Department of Internal Medicine, State University of New York: Downstate Medical Center, Brooklyn, New York, United States-11203. Email:
smcfarlane@downstate.eduAbstract
Thrombosis is one of the major underlying pathogenetic mechanisms leading to increased morbidity and mortality among COVID-19 patients. Thromboembolic events as well as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are the major causes of death in this continued pandemic. While elevated D-dimer level suggests worse thrombotic outcomes, levels at which benefits of anticoagulation outweigh the bleeding risk is yet to be determined. In this report, we present a case of a 72-year-old man with COVID-19 presented with confusion and subsequently developed acute hypoxic respiratory failure. On hospital day 7, patient developed extensive peripheral arterial thrombosis with acute rise of D-dimer from 800 to 14,899 ng/ml. He was treated with heparin drip and underwent urgent brachial, radial and ulnar embolectomy under general anesthesia. In this report, we also discuss the pathogenetic mechanisms and management of thromboembolism in COVID-19 patients, highlighting the role of early detection and aggressive therapeutic interventions that could be life and / or limb saving strategy.
Keywords